Increasing adoption of minimally invasive surgeries, rapidly aging population, and rising number of laparoscopic procedures are among the major factors driving this market’s growth.
The global insufflation devices market size is expected to hit around US$ 5.76 billion by 2030 from valued at US$ 5.31 billion in 2020 with a CAGR of 9.3% during forecast period 2021 to 2030.
Growth Factors
Increasing adoption of minimally invasive surgeries, rapidly aging population, and rising number of laparoscopic procedures are among the major factors driving this market’s growth.
Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38604
The COVID-19 outbreakhas caused the global implementation of strict measures to curbthe spread, which has led to the cancelation/delayof elective surgeries, including many laparoscopic procedures world wide. A large number of medical device manufacturing companies and global suppliers have been adversely affected during this time. However, with the abundance of deferred medical procedures in the pipeline, the market is likely to rebound and grow significantly over the forecast period.
Report Coverage
| Report Scope | Details |
| Market Size | USD 5.76 billion by 2030 |
| Growth Rate | CAGR of 9.3% From 2021 to 2030 |
| Base Year | 2021 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Application, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Fujifilm; Medtronic; Stryker; BD; Olympus; B. Braun Melsungen; Smith & Nephew; Karl Storz; Steris; CONMED; Richard Wolf |
Application Insights
The laparoscopic surgery segment held the largest share of over 35.0% in 2020 and is anticipated to witness considerable growth over the forecast period. The increasing cases of different laparoscopic surgical techniques, such as laparoscopic cholecystectomy, laparoscopic hernia repair, laparoscopic splenectomy, and laparoscopic hepatectomy, across the globe, are driving the segment. The multiple benefits of laparoscopic surgery include reduced postoperative pain, improved cosmetic results, enhanced patient satisfaction, and reduced hospital stay.
The other surgeries segment is expected to expand at the highest CAGR of 7.1% from the forecast period. The increasing number of surgeries such as carotid artery surgery, cataract surgery, and tonsillectomy is expected to drive the segment. For instance, as per the American Academy of Ophthalmology, around 24.4 million people aged 40 years are affected by cataracts. Furthermore, the increasing prevalence of stroke has led to an increase in carotid artery surgery.
Ask here for more details@ https://www.visionresearchreports.com/report/enquiry/38604
End-use Insights
The hospitals segment held the largest share of more than 60.0% in 2020. The growth of this segment can be attributed to the upsurge in surgical procedures globally because of a sedentary lifestyle, bad dietary habits, and rising cancer cases, which require the use of insufflation devices. Furthermore, the availability of technologically advanced insufflation devices, such aspersufflator, which is designed mainly for laparoscopy and carbon dioxide laser endoscopic surgery, will further enhance the market growth during the forecast period.
The ambulatory surgical centers segment is anticipated to register the fastest growth rate of 7.4% over the forecast period. An increase in the demand for minimally invasive surgeries, such as laparoscopic surgery, and increasing adoption of technologically advanced medical products by ambulatory surgical centers are a few factors fueling the market growth.
Regional Insights
North America dominated the market with as hare of over 35.0% in 2020 and is expected to witness considerable growth over the forecast period. The growth of this regional market is attributed to the increase in the prevalence of laparoscopic surgeries, such as hysterectomy and cholecystectomy, and a rise in the demand for minimally invasive procedures. Technological advancements are also contributing to the growth of the market in North America. Therefore, North America is expected to dominate the market over the forecast period.
The Asia Pacific market is anticipated to witness the fastest growth over the forecast period. The increasing prevalence of obesity and heart disorders, along with unmet demand for effective and long-term treatment solutions, is expected to present significant growth opportunities for insufflation devices in this region. Moreover, the rising preference for clinical trials and high R&D investments by global market players owing to their low-cost structure is high-impact rendering drivers for the market in the Asia Pacific region.
Key Players
- Fujifilm
- Medtronic
- Stryker
- BD
- Olympus
- B. Braun Melsungen
- Smith & Nephew
- Karl Storz
- Steris
- CONMED
- Richard Wolf
Market Segmentation
- Application
- Laparoscopic Surgery
- Bariatric Surgery
- Cardiac Surgery
- Other Surgeries
- End-use
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Regional
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Click Here to View Full Report Table of Contents
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38604
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333